Clariness
Matthijs W. de Boer is an experienced science communicator and researcher with a diverse background in neuroscience and medical writing. Currently serving as a Science Writer for the Human Brain Project since December 2022, Matthijs also works as a Freelance Writer for LabTwin, focusing on user communication and the enhancement of an Automatic Transcription model. With a strong foundation in journalism as a Freelance Journalist since September 2019, Matthijs has held various editorial and writing roles, including Medical Writer & Education Manager at Medcon International and Editor at New Scientist NL. Academic qualifications include a Master of Science in Neuroscience and a Bachelor of Science in Biomedical Sciences from Vrije Universiteit Amsterdam, complemented by a certificate in science journalism. Research experience spans studies on optogenetic therapies, Drosophila learning and memory, and animal behavior.
This person is not in any teams
Clariness
At Clariness, their mission is to bring medical innovations to market faster by accelerating clinical trials.While they are by no means alone in this mission, they believe they are the best choice for ensuring timely completion of your trial. Their confidence derives in part from the experiences recounted by multiple sponsors who have enlistedtheir patient recruitment and analysis services to rescue faltering trials initiated elsewhere.When you choose Clariness, you gain access to their winning combination of smart people, smart data, and smart technology. They are a team of dynamic, inquisitive and diverse individuals with a strong entrepreneurial spirit and a passion for developing innovative, web-based trial feasibility and recruitment applications, including the pioneering ClinLife® turnkey patient portal. They take pride in continually improving and adapting their services by incorporating new technologies and processes to better support the needs of their clients.With an established worldwide network of patients and investigators and sound business practices that have garnered a 93% approval rate following initial EC/IRB submission, Clariness has everything you expect from a global patient recruitment company, and everything you need to keep your trial on track.